NanoVibronix, Inc.
NAOV
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease paā¦ read more
Healthcare
Medical Devices
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$4.65
Price-3.13%
-$0.15
1Y
Price
Market Cap
$3.706m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-688.5%
EBITDA Margin-31.6%
Net Profit Margin-685.6%
Free Cash Flow MarginRevenue
$2.339m
-8.6%
1y CAGR+69.0%
3y CAGR+37.9%
5y CAGREarnings
-$5.080m
-37.1%
1y CAGR-1.7%
3y CAGR+14.2%
5y CAGREPS
-$12.82
+6.6%
1y CAGR+28.9%
3y CAGR+38.2%
5y CAGRBook Value
$40.477m
$51.482m
Assets$11.005m
Liabilities$2.125m
DebtDebt to Assets
4.1%
-0.3x
Debt to EBITDAFree Cash Flow
-$6.119m
-142.9%
1y CAGR-21.3%
3y CAGR-31.3%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company